These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22563510)

  • 1. Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis.
    Sharma M; Sehgal R; Kaur S
    PLoS Negl Trop Dis; 2012; 6(5):e1629. PubMed ID: 22563510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.
    Kaur T; Makkar P; Randhawa K; Kaur S
    Parasitol Res; 2013 Jan; 112(1):91-100. PubMed ID: 22961311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial effect of cisplatin against murine visceral leishmaniasis.
    Kaur S; Sachdeva H; Dhuria S; Sharma M; Kaur T
    Parasitol Int; 2010 Mar; 59(1):62-9. PubMed ID: 19853668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin along with herbal drug treatment reduces the percentage of regulatory T cells and decreased the severity of experimental visceral leishmaniasis.
    Sachdeva H; Kaur S
    J Microbiol Immunol Infect; 2018 Aug; 51(4):435-445. PubMed ID: 28655574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kDa + MPL-A against Leishmania donovani in BALB/c mice.
    Joshi J; Kaur S
    Parasite Immunol; 2014 Jan; 36(1):3-12. PubMed ID: 23964700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.
    Freitas EO; Nico D; Alves-Silva MV; Morrot A; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004297. PubMed ID: 26701750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
    Islamuddin M; Chouhan G; Farooque A; Dwarakanath BS; Sahal D; Afrin F
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3321. PubMed ID: 25568967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
    Joshi J; Malla N; Kaur S
    Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo.
    Sachdeva H; Sehgal R; Kaur S
    Parasitol Int; 2014 Feb; 63(1):21-30. PubMed ID: 24103199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
    Joshi J; Kaur S
    Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
    Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
    Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.
    Shivahare R; Vishwakarma P; Parmar N; Yadav PK; Haq W; Srivastava M; Gupta S; Kar S
    PLoS One; 2014; 9(4):e94596. PubMed ID: 24732039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus.
    Kaur S; Chauhan K; Sachdeva H
    J Med Microbiol; 2014 Oct; 63(Pt 10):1328-1338. PubMed ID: 25082945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
    Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
    Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.
    Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S
    Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
    Asad M; Bhattacharya P; Banerjee A; Ali N
    BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
    Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
    Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.